SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-9.94%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$218M
AUM Growth
+$218M
(-0.84%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
7.24%
Top 10 Holdings %
Top 10 Hldgs %
83.54%
Holding
39
New
8
Increased
13
Reduced
2
Closed
16
Top Buys
| 1 |
Xeris Biopharma Holdings
XERS
|
$16.6M |
| 2 |
ADMA Biologics
ADMA
|
$14M |
| 3 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$10.9M |
| 4 |
Evolus
EOLS
|
$10.2M |
| 5 |
ATRS
Antares Pharma, Inc.
ATRS
|
$7.26M |
Top Sells
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$19.2M |
| 2 |
Galapagos
GLPG
|
$12.8M |
| 3 |
Gyre Therapeutics
GYRE
|
$10.8M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$9.16M |
| 5 |
AFMD
Affimed
AFMD
|
$7.18M |
Sector Composition
| 1 | Healthcare | 94.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $65.6M | 30.08% | 6,069,775 +268,027 | +5% | +$2.89M |
|
|
CTIC
2
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $21.8M | 10.02% | 8,800,358 +836,029 | +10% | +$2.07M |
|
|
3
Xeris Biopharma Holdings
XERS
$1.26B
| $16.6M | 7.61% | +5,656,373 | New | +$16.6M |
|
|
4
ADMA Biologics
ADMA
$4.12B
| $14M | 6.41% | +9,911,577 | New | +$14M |
|
5
Ovid Therapeutics
OVID
$91M
| $12.9M | 5.9% | 4,006,185 +753,293 | +23% | +$2.42M |
|
|
6
Evolus
EOLS
$494M
| $12.1M | 5.57% | 1,863,096 +1,563,096 | +521% | +$10.2M |
|
|
CFMS
7
DELISTED
Conformis, Inc. Common Stock
CFMS
| $11.2M | 5.16% | 14,768,823 +14,281,841 | +2,933% | +$10.9M |
|
8
Exagen
XGN
$217M
| $9.99M | 4.58% | 858,567 +467,930 | +120% | +$5.44M |
|
|
APEN
9
DELISTED
Apollo Endosurgery, Inc.
APEN
| $9.7M | 4.45% | 1,151,163 +239,038 | +26% | +$2.02M |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $8.2M | 3.76% | 2,297,360 +2,033,260 | +770% | +$7.26M |
|
|
OPTN
11
DELISTED
OptiNose
OPTN
| $6.23M | 2.86% | +3,844,230 | New | +$6.23M |
|
12
DiaMedica Therapeutics
DMAC
$295M
| $4.46M | 2.04% | 1,194,670 +1,028,895 | +621% | +$3.84M |
|
|
ATYR
13
aTyr Pharma
ATYR
$527M
| $3.93M | 1.8% | 525,531 +114,996 | +28% | +$859K |
|
14
Rezolute
RZLT
$619M
| $3.86M | 1.77% | +808,405 | New | +$3.86M |
|
15
Celcuity
CELC
$2.17B
| $3.16M | 1.45% | 239,433 -55,259 | -19% | -$729K |
|
16
Cidara Therapeutics
CDTX
$1.66B
| $2.94M | 1.35% | 2,311,530 +1,528,713 | +195% | +$1.94M |
|
17
Synlogic
SYBX
$17M
| $2.58M | 1.18% | 1,064,135 +64,135 | +6% | +$155K |
|
18
Avalo Therapeutics
AVTX
$122M
| $2.57M | 1.18% | 1,510,095 +660,095 | +78% | +$1.12M |
|
19
ANI Pharmaceuticals
ANIP
$2.03B
| $2.41M | 1.11% | +52,290 | New | +$2.41M |
|
|
CBAY
20
DELISTED
Cymabay Therapeutics
CBAY
| $1.01M | 0.47% | +300,000 | New | +$1.01M |
|
21
NeuroOne Medical Technologies
NMTC
$38.2M
| $967K | 0.44% | +498,354 | New | +$967K |
|
22
Xoma
XOMA
$392M
| $960K | 0.44% | 46,026 -22,516 | -33% | -$470K |
|
23
Aldeyra Therapeutics
ALDX
$351M
| $800K | 0.37% | +200,000 | New | +$800K |
|
|
AFMD
24
DELISTED
Affimed
AFMD
| – | – | -1,161,466 | Closed | -$7.18M |
|
25
Elicio Therapeutics
ELTX
$172M
| – | – | -280,183 | Closed | -$2.74M |
|